Results from the world’s largest prospective artificial intelligence study revealed the system could significantly benefit breast cancer screening programs.
The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
Rather than administering radiolabeled glucose for exams, imagers give patients a small amount of a harmless glucose solution that is said to be equivalent to a can of a carbonated drink.
Every industry on earth is buzzing over the promise and potential of ChatGPT and similarly sharp AI models, whether “large language” or another generative form. Healthcare is no exception. But shouldn’t it be?
A new laser imaging technology may be able to determine which donor hearts are viable for transplant and which will result in poor outcomes, without the need for coronary angiography or use of contrast agents that can damage an explanted heart.
A team of experts recently developed the new system to differentiate between malignant and benign "second look" lesions on MRI for women with known breast cancer.
Those who undergo repeated exams before the age of 6 face almost double the risk of later developing intracranial tumors, leukemia or lymphoma, according to new data.
That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.
The hope is that the technique could lead to earlier detection of diseases by simultaneously identifying structural and functional abnormalities that standard ultrasound imaging methods alone cannot.
